Differential impact of constrictive physiology after pericardiocentesis in malignancy patients with pericardial effusion

In Jeong Cho, Hyuk-Jae Chang, Hyemoon Chung, Sang Eun Lee, ChiYoung Shim, Geu Ru Hong, Jong Won Ha, Namsik Chung

Research output: Contribution to journalArticle

Abstract

Background: Echocardiographic signs of constrictive physiology (CP) after pericardiocentesis are frequently observed in malignancy patients. The purpose of the current study was to explore whether features of CP after pericardiocentesis have prognostic impact in malignancy patients with pericardial effusion (PE). Methods: We retrospectively reviewed 467 consecutive patients who underwent pericardiocentesis at our institution from January 2006 to May 2014. Among them, 205 patients with advanced malignancy who underwent comprehensive echocardiography after the procedure comprised the study population. Co-primary end points were all-cause mortality (ACM) and repeated drainage (RD) for PE. Patients were divided into four subgroups according to cytologic result for malignant cells and CP (positive cytology with negative CP, both positive, both negative, and negative cytology with positive CP). Results: CP after pericardiocentesis was present in 106 patients (50%) at median 4 days after the procedure. During median follow-up of 208 days, ACM and RD occurred in 162 patients (79%) and 29 patients (14%), respectively. Cox regression analysis revealed that independent predictors for ACM were male gender and positive cytology (all, p < 0.05). For RD, predictors were positive cytology, the absence of cardiac tamponade, and negative CP after pericardiocentesis (all, p < 0.05). When the patients were divided into four subgroups, patients with negative cytology and positive CP demonstrated the most favorable survival (hazard ratio [HR]: 0.39, p = 0.005) and the lowest RD rates (HR: 0.07, p = 0.012). Conclusion: CP after pericardiocentesis is common, but does not always imply poor survival or the need for RD in patients with advanced malignancies. On the contrary, the presence of CP in patients with negative cytology conferred the most favorable survival and the lowest rate of RD. Comprehensive echocardiographic evaluation for CP after pericardiocentesis would be helpful for predicting prognosis in patients with advanced malignancies.

Original languageEnglish
Article numbere0145461
JournalPloS one
Volume10
Issue number12
DOIs
Publication statusPublished - 2015 Dec 1

Fingerprint

Pericardiocentesis
pericardial effusion
Pericardial Effusion
Physiology
Cytology
physiology
Drainage
cell biology
Neoplasms
Cell Biology
drainage
Hazards
Mortality
Echocardiography
Cell Physiological Phenomena
Cardiac Tamponade
Survival
Regression analysis
echocardiography
prognosis

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Cho, In Jeong ; Chang, Hyuk-Jae ; Chung, Hyemoon ; Lee, Sang Eun ; Shim, ChiYoung ; Hong, Geu Ru ; Ha, Jong Won ; Chung, Namsik. / Differential impact of constrictive physiology after pericardiocentesis in malignancy patients with pericardial effusion. In: PloS one. 2015 ; Vol. 10, No. 12.
@article{92f233e87efc4504add89a1ff5e22e39,
title = "Differential impact of constrictive physiology after pericardiocentesis in malignancy patients with pericardial effusion",
abstract = "Background: Echocardiographic signs of constrictive physiology (CP) after pericardiocentesis are frequently observed in malignancy patients. The purpose of the current study was to explore whether features of CP after pericardiocentesis have prognostic impact in malignancy patients with pericardial effusion (PE). Methods: We retrospectively reviewed 467 consecutive patients who underwent pericardiocentesis at our institution from January 2006 to May 2014. Among them, 205 patients with advanced malignancy who underwent comprehensive echocardiography after the procedure comprised the study population. Co-primary end points were all-cause mortality (ACM) and repeated drainage (RD) for PE. Patients were divided into four subgroups according to cytologic result for malignant cells and CP (positive cytology with negative CP, both positive, both negative, and negative cytology with positive CP). Results: CP after pericardiocentesis was present in 106 patients (50{\%}) at median 4 days after the procedure. During median follow-up of 208 days, ACM and RD occurred in 162 patients (79{\%}) and 29 patients (14{\%}), respectively. Cox regression analysis revealed that independent predictors for ACM were male gender and positive cytology (all, p < 0.05). For RD, predictors were positive cytology, the absence of cardiac tamponade, and negative CP after pericardiocentesis (all, p < 0.05). When the patients were divided into four subgroups, patients with negative cytology and positive CP demonstrated the most favorable survival (hazard ratio [HR]: 0.39, p = 0.005) and the lowest RD rates (HR: 0.07, p = 0.012). Conclusion: CP after pericardiocentesis is common, but does not always imply poor survival or the need for RD in patients with advanced malignancies. On the contrary, the presence of CP in patients with negative cytology conferred the most favorable survival and the lowest rate of RD. Comprehensive echocardiographic evaluation for CP after pericardiocentesis would be helpful for predicting prognosis in patients with advanced malignancies.",
author = "Cho, {In Jeong} and Hyuk-Jae Chang and Hyemoon Chung and Lee, {Sang Eun} and ChiYoung Shim and Hong, {Geu Ru} and Ha, {Jong Won} and Namsik Chung",
year = "2015",
month = "12",
day = "1",
doi = "10.1371/journal.pone.0145461",
language = "English",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "12",

}

Differential impact of constrictive physiology after pericardiocentesis in malignancy patients with pericardial effusion. / Cho, In Jeong; Chang, Hyuk-Jae; Chung, Hyemoon; Lee, Sang Eun; Shim, ChiYoung; Hong, Geu Ru; Ha, Jong Won; Chung, Namsik.

In: PloS one, Vol. 10, No. 12, e0145461, 01.12.2015.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Differential impact of constrictive physiology after pericardiocentesis in malignancy patients with pericardial effusion

AU - Cho, In Jeong

AU - Chang, Hyuk-Jae

AU - Chung, Hyemoon

AU - Lee, Sang Eun

AU - Shim, ChiYoung

AU - Hong, Geu Ru

AU - Ha, Jong Won

AU - Chung, Namsik

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Background: Echocardiographic signs of constrictive physiology (CP) after pericardiocentesis are frequently observed in malignancy patients. The purpose of the current study was to explore whether features of CP after pericardiocentesis have prognostic impact in malignancy patients with pericardial effusion (PE). Methods: We retrospectively reviewed 467 consecutive patients who underwent pericardiocentesis at our institution from January 2006 to May 2014. Among them, 205 patients with advanced malignancy who underwent comprehensive echocardiography after the procedure comprised the study population. Co-primary end points were all-cause mortality (ACM) and repeated drainage (RD) for PE. Patients were divided into four subgroups according to cytologic result for malignant cells and CP (positive cytology with negative CP, both positive, both negative, and negative cytology with positive CP). Results: CP after pericardiocentesis was present in 106 patients (50%) at median 4 days after the procedure. During median follow-up of 208 days, ACM and RD occurred in 162 patients (79%) and 29 patients (14%), respectively. Cox regression analysis revealed that independent predictors for ACM were male gender and positive cytology (all, p < 0.05). For RD, predictors were positive cytology, the absence of cardiac tamponade, and negative CP after pericardiocentesis (all, p < 0.05). When the patients were divided into four subgroups, patients with negative cytology and positive CP demonstrated the most favorable survival (hazard ratio [HR]: 0.39, p = 0.005) and the lowest RD rates (HR: 0.07, p = 0.012). Conclusion: CP after pericardiocentesis is common, but does not always imply poor survival or the need for RD in patients with advanced malignancies. On the contrary, the presence of CP in patients with negative cytology conferred the most favorable survival and the lowest rate of RD. Comprehensive echocardiographic evaluation for CP after pericardiocentesis would be helpful for predicting prognosis in patients with advanced malignancies.

AB - Background: Echocardiographic signs of constrictive physiology (CP) after pericardiocentesis are frequently observed in malignancy patients. The purpose of the current study was to explore whether features of CP after pericardiocentesis have prognostic impact in malignancy patients with pericardial effusion (PE). Methods: We retrospectively reviewed 467 consecutive patients who underwent pericardiocentesis at our institution from January 2006 to May 2014. Among them, 205 patients with advanced malignancy who underwent comprehensive echocardiography after the procedure comprised the study population. Co-primary end points were all-cause mortality (ACM) and repeated drainage (RD) for PE. Patients were divided into four subgroups according to cytologic result for malignant cells and CP (positive cytology with negative CP, both positive, both negative, and negative cytology with positive CP). Results: CP after pericardiocentesis was present in 106 patients (50%) at median 4 days after the procedure. During median follow-up of 208 days, ACM and RD occurred in 162 patients (79%) and 29 patients (14%), respectively. Cox regression analysis revealed that independent predictors for ACM were male gender and positive cytology (all, p < 0.05). For RD, predictors were positive cytology, the absence of cardiac tamponade, and negative CP after pericardiocentesis (all, p < 0.05). When the patients were divided into four subgroups, patients with negative cytology and positive CP demonstrated the most favorable survival (hazard ratio [HR]: 0.39, p = 0.005) and the lowest RD rates (HR: 0.07, p = 0.012). Conclusion: CP after pericardiocentesis is common, but does not always imply poor survival or the need for RD in patients with advanced malignancies. On the contrary, the presence of CP in patients with negative cytology conferred the most favorable survival and the lowest rate of RD. Comprehensive echocardiographic evaluation for CP after pericardiocentesis would be helpful for predicting prognosis in patients with advanced malignancies.

UR - http://www.scopus.com/inward/record.url?scp=84958230927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958230927&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0145461

DO - 10.1371/journal.pone.0145461

M3 - Article

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 12

M1 - e0145461

ER -